Hematological analysis revealed moderate anemia (HCT 21%, RI 32–48%), while serum biochemistry showed increased urea levels (90 mg/dL, RI 30–65 mg/dL) and marked elevations in hepatomuscular enzymes (ALT 591 U/L, RI 20–72 U/L; AST 418 U/L, RI 9–40 U/L). The gene discussed is GPT; the disease is anemia.